Artwork

Content provided by BioTechniques. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioTechniques or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Next-generation antibody therapeutics

24:52
 
Share
 

Manage episode 385244007 series 2902208
Content provided by BioTechniques. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioTechniques or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode of Talking Techniques, we speak to two experts from Sino Biological US Inc. (PA, USA) about the latest developments in antibody technologies and how these developments have led to the next generation of antibodies that are revolutionizing therapeutic approaches to a number of diseases.

With the guidance of Field Scientist Ritwika Biswas and Technical Account Manager Grace Liu, we explore the challenges of developing and working with next-generation antibodies, the latest developments and applications of these molecules and the holy grail that antibody designers are driving towards.


Contents:

  • Introduction: 00:00 – 02:40
  • The history of monoclonal antibody therapeutics: 02:40 – 04:40
  • The working principles of multi-specific antibodies: 04:40 – 08:15
  • Recent developments in ADCs: 08:15 – 11:35
  • Challenges with the development of multi-specific antibodies and ADCs: 11:35 – 13:55
  • Solutions to address these challenges: 13:55 – 16:25
  • Clinical applications of multi-specific antibodies and ADCs: 16:25 – 20:30
  • The dream of real-time adaptability for the next generation of antibody therapeutics: 20:30 – 24:52


Hosted on Acast. See acast.com/privacy for more information.

  continue reading

59 episodes

Artwork
iconShare
 
Manage episode 385244007 series 2902208
Content provided by BioTechniques. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioTechniques or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode of Talking Techniques, we speak to two experts from Sino Biological US Inc. (PA, USA) about the latest developments in antibody technologies and how these developments have led to the next generation of antibodies that are revolutionizing therapeutic approaches to a number of diseases.

With the guidance of Field Scientist Ritwika Biswas and Technical Account Manager Grace Liu, we explore the challenges of developing and working with next-generation antibodies, the latest developments and applications of these molecules and the holy grail that antibody designers are driving towards.


Contents:

  • Introduction: 00:00 – 02:40
  • The history of monoclonal antibody therapeutics: 02:40 – 04:40
  • The working principles of multi-specific antibodies: 04:40 – 08:15
  • Recent developments in ADCs: 08:15 – 11:35
  • Challenges with the development of multi-specific antibodies and ADCs: 11:35 – 13:55
  • Solutions to address these challenges: 13:55 – 16:25
  • Clinical applications of multi-specific antibodies and ADCs: 16:25 – 20:30
  • The dream of real-time adaptability for the next generation of antibody therapeutics: 20:30 – 24:52


Hosted on Acast. See acast.com/privacy for more information.

  continue reading

59 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide